Development of a novel Indium-111 radiolabeled mogamulizumab targeting CCR4 for imaging adult T-cell leukemia/lymphoma in vivo.
Yoichi ShimizuSho KoyasuMari SuzukidaKiyotaka IzumiEitaro KideraTakero ShindoTsuneo SagaMasahiro OnoAkifumi Takaori-KondoYuji NakamotoPublished in: Annals of nuclear medicine (2022)
In]In-DTPA-mogamulizumab, which showed good specificity and pharmacokinetics, indicating potential in visualizing CCR4 expression in vivo.